High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myeloma.

Kawano, M M; Mahmoud, M S; Huang, N; Lisukov, I A; Mihara, K; Tsujimoto, T; Kuramoto, A

Kawano, M M; Mahmoud, M S; Huang, N; Lisukov, I A; Mihara, K; Tsujimoto, T; Kuramoto, A.

Affiliation

Kawano MM; Department of Internal Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan.

Br J Haematol ; 91(4): 860-4, 1995 Dec.

Article in En | MEDLINE | ID: mdl-8547130

Subject(s)

Multiple Myeloma/immunology; Plasma Cells/immunology; Receptors, Very Late Antigen; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Adult; Aged; Antigens, CD; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Humans; Immunophenotyping; Membrane Glycoproteins; Middle Aged; Multiple Myeloma/drug therapy; Multiple Myeloma/pathology; N-Glycosyl Hydrolases; Prognosis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasma Cells / Receptors, Very Late Antigen / Multiple Myeloma Type of study: Prognostic_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Br J Haematol Year: 1995 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links